Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02538666
Brief Title: An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy (CheckMate 451)

First Submitted : August 26, 2015
First Submitted that Met QC Criteria : September 1, 2015
First Posted : September 2, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : December 3, 2018
Last Update Posted : December 4, 2018